TRAF3 interacting protein 2 (TRAF3IP2; ACT1); inducible nitric oxide synthase 2 (NOS2; iNOS); F-box and leucine-rich repeat protein 19 (FBXL19); nuclear factor of κ light polypeptide gene enhancer in B cells inhibitor α (NKFBIA); proteasome subunit α-type 6 (PSMA6); endoplasmic reticulum aminopeptidase 1 (ERAP1); pituitary tumor-transforming gene 1 (PTTG1); CUB and sushi multiple domains 1 (CSMD1); gap junction protein β2,

doi:10.1038/scibx.2010.1437

TRAF3 interacting protein 2 (TRAF3IP2; ACT1); inducible nitric oxide synthase 2 (NOS2; iNOS); F-box and leucine-rich repeat protein 19 (FBXL19); nuclear factor of κ light polypeptide gene enhancer in B cells inhibitor α (NKFBIA); proteasome subunit α-type 6 (PSMA6); endoplasmic reticulum aminopeptidase 1 (ERAP1); pituitary tumor-transforming gene 1 (PTTG1); CUB and sushi multiple domains 1 (CSMD1); gap junction protein β2,

Open Access

https://doi.org/10.1038/scibx.2010.1437

Copy DOI

Journal: Science-Business eXchange

Publication Date: Dec 1, 2010

#CUB And Sushi Multiple Domains 1 #Pituitary Tumor-transforming Gene 1 + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

TRAF3 interacting protein 2 (TRAF3IP2; ACT1); inducible nitric oxide synthase 2 (NOS2; iNOS); F-box and leucine-rich repeat protein 19 (FBXL19); nuclear factor of κ light polypeptide gene enhancer in B cells inhibitor α (NKFBIA); proteasome subunit α-type 6 (PSMA6); endoplasmic reticulum aminopeptidase 1 (ERAP1); pituitary tumor-transforming gene 1 (PTTG1); CUB and sushi multiple domains 1 (CSMD1); gap junction protein β2,

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Science-Business eXchange

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.